Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BULLETIN
October 21, 2002
- DIAGNOSTIC NEWS IN BRIEF
October 21, 2002
- The 61st Annual Meeting of the Japanese Cancer Associarion
October 21, 2002
- 21st IFPMA Assembly Held in Berlin
October 21, 2002
- Communication Is Most Important in Int'l Collaborative Studies: Prof. Uchida
October 21, 2002
- Korosho Study Group Recommends AUTs for OTC Drugs
October 21, 2002
- OTC NEWS IN BRIEF
October 21, 2002
- ON THE MOVE
October 21, 2002
- Tanabe Stresses Enhancement of Competitiveness as Research-oriented Firm: President Hayama
October 21, 2002
- Fujisawa Introduces Atlas Data Suit from Gene Logic
October 21, 2002
- Healthcare Expenditures Down 1.6% in 2nd QTR VS 1st QTR
October 14, 2002
- REGULATORY NEWS IN BRIEF
October 14, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 14, 2002
- Physician-led Trials to Start on New Indication for Irinotecan
October 14, 2002
- Korosho Pledges to Smoothly Implement New Blood Law
October 14, 2002
- Korosho to Give Priority to Useful Drugs in Clinical Trial Consultation
October 14, 2002
- New ADR Information System under Investigation
October 14, 2002
- BUSINESS NEWS IN BRIEF
October 14, 2002
- WORLD NEWS IN BRIEF
October 14, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
October 14, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…